NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 826.00
-8.20 (-0.98%)
Oct 24, 2025, 12:58 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 149.41 billion as of October 23, 2025. Its market cap has decreased by -38.78% in one year.
Market Cap
149.41B
Enterprise Value
127.29B
Revenue
43.96B
Ranking
n/a
PE Ratio
8.80
Stock Price
826.00
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 149.41B, an increase of 34,696.80%. That is a compound annual growth rate of 24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 150.81B | -39.31% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | 175.25B | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.32T |
| Apollo Hospitals Enterprise | 1.15T |
| Mankind Pharma | 1.01T |
| Zydus Lifesciences | 1.01T |
| Fortis Healthcare | 825.17B |
| Alkem Laboratories | 664.42B |